Ketogenic Diet: Animal Models of the Ketogenic Diet and Other Dietary Therapies

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The ketogenic diet (KD) is an effective therapy for many children and adults with epilepsy who are refractory to conventional antiepileptic drugs. Possible mechanisms of the KD include direct effects of ketones or lipids on neuronal excitability, enhancement of inhibitory GABAergic function, or alteration of energy metabolism. Another possibility, arising from the fact that carbohydrates are restricted in the KD, is that inhibition of glycolysis (the primary route of glucose catabolism in mammalian cells) might provide an antiepileptic effect. Experiments described in this article show that the glycolysis inhibitor, 2-deoxy-. d-glucose, exerts both anticonvulsant and antiepileptic effects in a variety of animal models. Anticonvulsant effects include increase in the afterdischarge threshold in perforant path kindled rats, and decrease in epileptic burst frequency in several models of interictal bursting (including high potassium, 4-aminopyridine, and bicuculline). Antiepileptic effects include the decrease in progression of afterdischarge threshold in kindling of the perforant path, and slowing of kindling progression with perforant path or olfactory bulb stimulation. These findings indicate that 2-deoxy-. d-glucose, a safe compound already used for decades in positron emission tomography imaging, might be a novel agent for seizure control in patients with refractory epilepsy.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Basic Epilepsy Research
PublisherElsevier Inc.
Pages677-681
Number of pages5
ISBN (Print)9780123739612
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Ketogenic Diet
Anticonvulsants
Animal Models
Perforant Pathway
Glycolysis
Glucose
Epilepsy
Therapeutics
4-Aminopyridine
Bicuculline
Olfactory Bulb
Ketones
Positron-Emission Tomography
Energy Metabolism
Potassium
Seizures
Carbohydrates
Lipids

Keywords

  • Animal models
  • Calorie restriction
  • Epilepsy
  • Glycolysis
  • Ketogenic diet

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Ketogenic Diet : Animal Models of the Ketogenic Diet and Other Dietary Therapies. / Stafstrom, C. E.

Encyclopedia of Basic Epilepsy Research. Elsevier Inc., 2009. p. 677-681.

Research output: Chapter in Book/Report/Conference proceedingChapter

Stafstrom, C. E. / Ketogenic Diet : Animal Models of the Ketogenic Diet and Other Dietary Therapies. Encyclopedia of Basic Epilepsy Research. Elsevier Inc., 2009. pp. 677-681
@inbook{b9d246388c48479482b750c9f851900b,
title = "Ketogenic Diet: Animal Models of the Ketogenic Diet and Other Dietary Therapies",
abstract = "The ketogenic diet (KD) is an effective therapy for many children and adults with epilepsy who are refractory to conventional antiepileptic drugs. Possible mechanisms of the KD include direct effects of ketones or lipids on neuronal excitability, enhancement of inhibitory GABAergic function, or alteration of energy metabolism. Another possibility, arising from the fact that carbohydrates are restricted in the KD, is that inhibition of glycolysis (the primary route of glucose catabolism in mammalian cells) might provide an antiepileptic effect. Experiments described in this article show that the glycolysis inhibitor, 2-deoxy-. d-glucose, exerts both anticonvulsant and antiepileptic effects in a variety of animal models. Anticonvulsant effects include increase in the afterdischarge threshold in perforant path kindled rats, and decrease in epileptic burst frequency in several models of interictal bursting (including high potassium, 4-aminopyridine, and bicuculline). Antiepileptic effects include the decrease in progression of afterdischarge threshold in kindling of the perforant path, and slowing of kindling progression with perforant path or olfactory bulb stimulation. These findings indicate that 2-deoxy-. d-glucose, a safe compound already used for decades in positron emission tomography imaging, might be a novel agent for seizure control in patients with refractory epilepsy.",
keywords = "Animal models, Calorie restriction, Epilepsy, Glycolysis, Ketogenic diet",
author = "Stafstrom, {C. E.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/B978-012373961-2.00184-3",
language = "English (US)",
isbn = "9780123739612",
pages = "677--681",
booktitle = "Encyclopedia of Basic Epilepsy Research",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Ketogenic Diet

T2 - Animal Models of the Ketogenic Diet and Other Dietary Therapies

AU - Stafstrom, C. E.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - The ketogenic diet (KD) is an effective therapy for many children and adults with epilepsy who are refractory to conventional antiepileptic drugs. Possible mechanisms of the KD include direct effects of ketones or lipids on neuronal excitability, enhancement of inhibitory GABAergic function, or alteration of energy metabolism. Another possibility, arising from the fact that carbohydrates are restricted in the KD, is that inhibition of glycolysis (the primary route of glucose catabolism in mammalian cells) might provide an antiepileptic effect. Experiments described in this article show that the glycolysis inhibitor, 2-deoxy-. d-glucose, exerts both anticonvulsant and antiepileptic effects in a variety of animal models. Anticonvulsant effects include increase in the afterdischarge threshold in perforant path kindled rats, and decrease in epileptic burst frequency in several models of interictal bursting (including high potassium, 4-aminopyridine, and bicuculline). Antiepileptic effects include the decrease in progression of afterdischarge threshold in kindling of the perforant path, and slowing of kindling progression with perforant path or olfactory bulb stimulation. These findings indicate that 2-deoxy-. d-glucose, a safe compound already used for decades in positron emission tomography imaging, might be a novel agent for seizure control in patients with refractory epilepsy.

AB - The ketogenic diet (KD) is an effective therapy for many children and adults with epilepsy who are refractory to conventional antiepileptic drugs. Possible mechanisms of the KD include direct effects of ketones or lipids on neuronal excitability, enhancement of inhibitory GABAergic function, or alteration of energy metabolism. Another possibility, arising from the fact that carbohydrates are restricted in the KD, is that inhibition of glycolysis (the primary route of glucose catabolism in mammalian cells) might provide an antiepileptic effect. Experiments described in this article show that the glycolysis inhibitor, 2-deoxy-. d-glucose, exerts both anticonvulsant and antiepileptic effects in a variety of animal models. Anticonvulsant effects include increase in the afterdischarge threshold in perforant path kindled rats, and decrease in epileptic burst frequency in several models of interictal bursting (including high potassium, 4-aminopyridine, and bicuculline). Antiepileptic effects include the decrease in progression of afterdischarge threshold in kindling of the perforant path, and slowing of kindling progression with perforant path or olfactory bulb stimulation. These findings indicate that 2-deoxy-. d-glucose, a safe compound already used for decades in positron emission tomography imaging, might be a novel agent for seizure control in patients with refractory epilepsy.

KW - Animal models

KW - Calorie restriction

KW - Epilepsy

KW - Glycolysis

KW - Ketogenic diet

UR - http://www.scopus.com/inward/record.url?scp=85069291446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069291446&partnerID=8YFLogxK

U2 - 10.1016/B978-012373961-2.00184-3

DO - 10.1016/B978-012373961-2.00184-3

M3 - Chapter

AN - SCOPUS:85069291446

SN - 9780123739612

SP - 677

EP - 681

BT - Encyclopedia of Basic Epilepsy Research

PB - Elsevier Inc.

ER -